

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * muscle filament sliding (GO:0030049) | 8.92331451 |
| 2 | * actin-myosin filament sliding (GO:0033275) | 8.92331451 |
| 3 | * sarcomere organization (GO:0045214) | 8.54903294 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 8.30393028 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.37987672 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.32743349 |
| 7 | plasma membrane repair (GO:0001778) | 7.29705304 |
| 8 | * actin-mediated cell contraction (GO:0070252) | 7.29007081 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.28992245 |
| 10 | * myofibril assembly (GO:0030239) | 6.95449643 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.63101551 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.47436636 |
| 13 | * cardiac myofibril assembly (GO:0055003) | 6.46183718 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 6.32213255 |
| 15 | regulation of relaxation of muscle (GO:1901077) | 6.17260567 |
| 16 | * cardiac muscle contraction (GO:0060048) | 5.88167337 |
| 17 | * striated muscle contraction (GO:0006941) | 5.85931798 |
| 18 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.81728693 |
| 19 | carnitine shuttle (GO:0006853) | 5.75645672 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.64395578 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.64095973 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.57772789 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.55773749 |
| 24 | * skeletal muscle contraction (GO:0003009) | 5.53015164 |
| 25 | * actomyosin structure organization (GO:0031032) | 5.47576997 |
| 26 | * actin filament-based movement (GO:0030048) | 5.42601517 |
| 27 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.30311972 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.25750903 |
| 29 | creatine metabolic process (GO:0006600) | 5.25636968 |
| 30 | skeletal muscle fiber development (GO:0048741) | 5.25607301 |
| 31 | skeletal muscle adaptation (GO:0043501) | 5.22611152 |
| 32 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.22219480 |
| 33 | * cardiac muscle cell development (GO:0055013) | 5.10132706 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 4.95618789 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.89406298 |
| 36 | regulation of sarcomere organization (GO:0060297) | 4.87402843 |
| 37 | regulation of coenzyme metabolic process (GO:0051196) | 4.81567432 |
| 38 | regulation of cofactor metabolic process (GO:0051193) | 4.81567432 |
| 39 | myotube cell development (GO:0014904) | 4.78662393 |
| 40 | * cardiac cell development (GO:0055006) | 4.77231131 |
| 41 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.77205633 |
| 42 | heart contraction (GO:0060047) | 4.74378344 |
| 43 | heart process (GO:0003015) | 4.74378344 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.73029721 |
| 45 | * cardiac muscle tissue morphogenesis (GO:0055008) | 4.53738887 |
| 46 | heart trabecula formation (GO:0060347) | 4.50207211 |
| 47 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.44625289 |
| 48 | * muscle contraction (GO:0006936) | 4.33039182 |
| 49 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.30741867 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.29476072 |
| 51 | carnitine transmembrane transport (GO:1902603) | 4.27502837 |
| 52 | response to inactivity (GO:0014854) | 4.21492252 |
| 53 | * muscle tissue morphogenesis (GO:0060415) | 4.21471915 |
| 54 | skeletal muscle tissue development (GO:0007519) | 4.16135017 |
| 55 | NADH metabolic process (GO:0006734) | 4.07929294 |
| 56 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.05904188 |
| 57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.04819452 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.04273470 |
| 59 | glycogen catabolic process (GO:0005980) | 4.03809892 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.00458471 |
| 61 | * muscle system process (GO:0003012) | 4.00147611 |
| 62 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.99224483 |
| 63 | response to muscle activity (GO:0014850) | 3.99122849 |
| 64 | * muscle fiber development (GO:0048747) | 3.93555836 |
| 65 | regulation of sulfur metabolic process (GO:0042762) | 3.92221784 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 3.90137996 |
| 67 | amino-acid betaine transport (GO:0015838) | 3.89347536 |
| 68 | carnitine transport (GO:0015879) | 3.89347536 |
| 69 | * cardiac muscle hypertrophy (GO:0003300) | 3.87186695 |
| 70 | respiratory electron transport chain (GO:0022904) | 3.87135103 |
| 71 | muscle cell cellular homeostasis (GO:0046716) | 3.81567616 |
| 72 | * striated muscle hypertrophy (GO:0014897) | 3.81015076 |
| 73 | oxidative phosphorylation (GO:0006119) | 3.80826029 |
| 74 | striated muscle atrophy (GO:0014891) | 3.79799722 |
| 75 | cytidine deamination (GO:0009972) | 3.79217504 |
| 76 | cytidine metabolic process (GO:0046087) | 3.79217504 |
| 77 | cytidine catabolic process (GO:0006216) | 3.79217504 |
| 78 | glucan catabolic process (GO:0009251) | 3.76667362 |
| 79 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.75485505 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.75485505 |
| 81 | electron transport chain (GO:0022900) | 3.75076295 |
| 82 | ATP synthesis coupled proton transport (GO:0015986) | 3.74796899 |
| 83 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.74796899 |
| 84 | regulation of the force of heart contraction (GO:0002026) | 3.73203889 |
| 85 | * adult heart development (GO:0007512) | 3.72345262 |
| 86 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.70493743 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.70493743 |
| 88 | regulation of ATP catabolic process (GO:1903289) | 3.64436322 |
| 89 | regulation of ATPase activity (GO:0043462) | 3.64436322 |
| 90 | skeletal muscle tissue regeneration (GO:0043403) | 3.63131228 |
| 91 | negative regulation of protein localization to cell surface (GO:2000009) | 3.61857896 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 3.60404910 |
| 93 | negative regulation of potassium ion transport (GO:0043267) | 3.58142030 |
| 94 | * striated muscle cell development (GO:0055002) | 3.56690267 |
| 95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55893781 |
| 96 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.55214949 |
| 97 | regulation of muscle contraction (GO:0006937) | 3.55009713 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.54111887 |
| 99 | muscle structure development (GO:0061061) | 3.53627091 |
| 100 | muscle organ development (GO:0007517) | 3.53016617 |
| 101 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.52569380 |
| 102 | positive regulation of cation channel activity (GO:2001259) | 3.52551510 |
| 103 | regulation of muscle system process (GO:0090257) | 3.52147267 |
| 104 | glycogen metabolic process (GO:0005977) | 3.51730733 |
| 105 | muscle cell fate commitment (GO:0042693) | 3.51562899 |
| 106 | cellular polysaccharide catabolic process (GO:0044247) | 3.50026493 |
| 107 | cardiac muscle cell action potential (GO:0086001) | 3.49436686 |
| 108 | positive regulation of myotube differentiation (GO:0010831) | 3.49402923 |
| 109 | negative regulation of muscle hypertrophy (GO:0014741) | 3.48189844 |
| 110 | gluconeogenesis (GO:0006094) | 3.45572210 |
| 111 | glycogen biosynthetic process (GO:0005978) | 3.44937418 |
| 112 | glucan biosynthetic process (GO:0009250) | 3.44937418 |
| 113 | glucan metabolic process (GO:0044042) | 3.44719744 |
| 114 | cellular glucan metabolic process (GO:0006073) | 3.44719744 |
| 115 | * striated muscle adaptation (GO:0014888) | 3.44470995 |
| 116 | regulation of cardiac muscle contraction (GO:0055117) | 3.42141339 |
| 117 | regulation of heart rate (GO:0002027) | 3.39730087 |
| 118 | regulation of myoblast differentiation (GO:0045661) | 3.36739708 |
| 119 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.36011150 |
| 120 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35687937 |
| 121 | polysaccharide catabolic process (GO:0000272) | 3.33777222 |
| 122 | relaxation of muscle (GO:0090075) | 3.32285209 |
| 123 | * muscle hypertrophy (GO:0014896) | 3.32256963 |
| 124 | response to activity (GO:0014823) | 3.27059573 |
| 125 | negative regulation of necroptotic process (GO:0060546) | 3.25321497 |
| 126 | relaxation of cardiac muscle (GO:0055119) | 3.24490436 |
| 127 | oxaloacetate metabolic process (GO:0006107) | 3.24025078 |
| 128 | regulation of heart contraction (GO:0008016) | 3.15417711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.66136175 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.23452543 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.08791718 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01436941 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.85883032 |
| 6 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.75036717 |
| 7 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.75036717 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.30330481 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.22811905 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.86137321 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.72515727 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.68117297 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.50529459 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.26717732 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.13701494 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.07897746 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04775940 |
| 18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.04635996 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99710904 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87423702 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.83329449 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79418599 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75214934 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61308622 |
| 25 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.59042702 |
| 26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.58636360 |
| 27 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.55755532 |
| 28 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.51790727 |
| 29 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.51212085 |
| 30 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.51056852 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.48785928 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41627898 |
| 33 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.41456106 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36184271 |
| 35 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33255829 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31134247 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30059796 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29481058 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26457740 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24919730 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21770252 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21133365 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20371331 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19400817 |
| 45 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18174451 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18129668 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17045823 |
| 48 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15884448 |
| 49 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.14274758 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14056527 |
| 51 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13451654 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12891821 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12090201 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.11580354 |
| 55 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10876499 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10875445 |
| 57 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07957435 |
| 58 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06386272 |
| 59 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.06055744 |
| 60 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05325020 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04309293 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03345111 |
| 63 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03258475 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02392422 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00818871 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00015256 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99907433 |
| 68 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99181829 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98785650 |
| 70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98747250 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98656375 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97542156 |
| 73 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95426697 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95422275 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95407763 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94377089 |
| 77 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94274628 |
| 78 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.93531427 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93438962 |
| 80 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91386294 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90999252 |
| 82 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90018834 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89826658 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89797390 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88945694 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88674706 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88206295 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86917175 |
| 89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86097437 |
| 90 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.85639185 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85156889 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85151132 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84744085 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84501834 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84432163 |
| 96 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83199454 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83087766 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83013502 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82940321 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82649072 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82408673 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81134693 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80639213 |
| 104 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80150140 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78189857 |
| 106 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78133912 |
| 107 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77860067 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77750278 |
| 109 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77241984 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76575590 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76566498 |
| 112 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76253808 |
| 113 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.75929626 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75478283 |
| 115 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75376226 |
| 116 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74852878 |
| 117 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.74344658 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74205751 |
| 119 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.73407795 |
| 120 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.73392828 |
| 121 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73217486 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.72932011 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72618177 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72568007 |
| 125 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.72512488 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71424468 |
| 127 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71201128 |
| 128 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.70816969 |
| 129 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.70816969 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70329210 |
| 131 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.69848148 |
| 132 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.68831933 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68071000 |
| 134 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68015040 |
| 135 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.67480129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.54729595 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.45121781 |
| 3 | * MP0000751_myopathy | 5.02826131 |
| 4 | MP0000749_muscle_degeneration | 4.92153047 |
| 5 | MP0004084_abnormal_cardiac_muscle | 4.69615064 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.39726814 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 4.10803450 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.95082520 |
| 9 | MP0005330_cardiomyopathy | 3.49450943 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.29400274 |
| 11 | * MP0002106_abnormal_muscle_physiology | 3.11324200 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.10021812 |
| 13 | MP0004130_abnormal_muscle_cell | 2.98427433 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.96098291 |
| 15 | MP0000747_muscle_weakness | 2.92021350 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.70935054 |
| 17 | * MP0000759_abnormal_skeletal_muscle | 2.63813453 |
| 18 | * MP0002269_muscular_atrophy | 2.61950297 |
| 19 | * MP0005369_muscle_phenotype | 2.55501773 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.35405919 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.33008586 |
| 22 | MP0004484_altered_response_of | 2.29564875 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.28269456 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.24707471 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.24707471 |
| 26 | MP0004233_abnormal_muscle_weight | 2.07185551 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.96975119 |
| 28 | MP0006138_congestive_heart_failure | 1.92252286 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.83790119 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.81465146 |
| 31 | MP0003828_pulmonary_edema | 1.69428081 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.64055946 |
| 33 | MP0004085_abnormal_heartbeat | 1.63890642 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.44945979 |
| 35 | MP0004510_myositis | 1.39870061 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.39362313 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.34049841 |
| 38 | MP0002108_abnormal_muscle_morphology | 1.28239038 |
| 39 | MP0000733_abnormal_muscle_development | 1.16350438 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.16293421 |
| 41 | MP0005670_abnormal_white_adipose | 1.14528111 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.12843688 |
| 43 | MP0000343_altered_response_to | 1.12053061 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.05656010 |
| 45 | MP0000266_abnormal_heart_morphology | 0.99182068 |
| 46 | MP0005266_abnormal_metabolism | 0.97922139 |
| 47 | MP0001661_extended_life_span | 0.95904458 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92881512 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 0.89948265 |
| 50 | MP0002971_abnormal_brown_adipose | 0.87177924 |
| 51 | MP0005165_increased_susceptibility_to | 0.85349748 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.83267446 |
| 53 | MP0005275_abnormal_skin_tensile | 0.75642756 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.70731561 |
| 55 | MP0004043_abnormal_pH_regulation | 0.70167586 |
| 56 | MP0003279_aneurysm | 0.70121917 |
| 57 | MP0010368_abnormal_lymphatic_system | 0.69386432 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.69090626 |
| 59 | MP0004147_increased_porphyrin_level | 0.64384031 |
| 60 | MP0002128_abnormal_blood_circulation | 0.63514000 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.62097136 |
| 62 | MP0008961_abnormal_basal_metabolism | 0.57589559 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.56218783 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.51726522 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.51662977 |
| 66 | MP0003566_abnormal_cell_adhesion | 0.49776096 |
| 67 | MP0005451_abnormal_body_composition | 0.48892726 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.48276443 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.43910923 |
| 70 | MP0005187_abnormal_penis_morphology | 0.43776826 |
| 71 | MP0005623_abnormal_meninges_morphology | 0.43380145 |
| 72 | MP0005334_abnormal_fat_pad | 0.41836866 |
| 73 | MP0000767_abnormal_smooth_muscle | 0.41609258 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.41440836 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 0.38269670 |
| 76 | MP0003879_abnormal_hair_cell | 0.37779073 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.37727476 |
| 78 | MP0005535_abnormal_body_temperature | 0.37442442 |
| 79 | MP0005423_abnormal_somatic_nervous | 0.36258138 |
| 80 | MP0005083_abnormal_biliary_tract | 0.36165825 |
| 81 | MP0004134_abnormal_chest_morphology | 0.34683342 |
| 82 | MP0002925_abnormal_cardiovascular_devel | 0.32251770 |
| 83 | MP0003011_delayed_dark_adaptation | 0.31569745 |
| 84 | MP0003948_abnormal_gas_homeostasis | 0.31054918 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30711366 |
| 86 | MP0000579_abnormal_nail_morphology | 0.29615594 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.28711469 |
| 88 | MP0002822_catalepsy | 0.28678364 |
| 89 | MP0005166_decreased_susceptibility_to | 0.27940687 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.27716119 |
| 91 | MP0003195_calcinosis | 0.26896347 |
| 92 | MP0009115_abnormal_fat_cell | 0.26820297 |
| 93 | MP0008569_lethality_at_weaning | 0.26757980 |
| 94 | MP0009840_abnormal_foam_cell | 0.26560845 |
| 95 | MP0003045_fibrosis | 0.26489790 |
| 96 | MP0001853_heart_inflammation | 0.26393094 |
| 97 | MP0005452_abnormal_adipose_tissue | 0.26217952 |
| 98 | MP0001614_abnormal_blood_vessel | 0.25463879 |
| 99 | MP0001784_abnormal_fluid_regulation | 0.25398034 |
| 100 | MP0005332_abnormal_amino_acid | 0.24375668 |
| 101 | MP0009672_abnormal_birth_weight | 0.23813056 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.23261507 |
| 103 | MP0004142_abnormal_muscle_tone | 0.22726471 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.22168237 |
| 105 | MP0010030_abnormal_orbit_morphology | 0.22158006 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.21411182 |
| 107 | MP0002114_abnormal_axial_skeleton | 0.20845906 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.19407525 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.18887520 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.18651016 |
| 111 | MP0004924_abnormal_behavior | 0.18651016 |
| 112 | MP0008874_decreased_physiological_sensi | 0.18511378 |
| 113 | MP0000249_abnormal_blood_vessel | 0.17856041 |
| 114 | MP0004270_analgesia | 0.17802678 |
| 115 | MP0002970_abnormal_white_adipose | 0.17267865 |
| 116 | MP0004272_abnormal_basement_membrane | 0.17201499 |
| 117 | MP0009250_abnormal_appendicular_skeleto | 0.16774892 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.16516428 |
| 119 | MP0001943_abnormal_respiration | 0.16174035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.91062506 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.51750081 |
| 3 | Sudden death (HP:0001699) | 6.53592794 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.28370736 |
| 5 | Muscle fiber splitting (HP:0003555) | 6.26926249 |
| 6 | * Muscle hypertrophy of the lower extremities (HP:0008968) | 6.06074916 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.99772660 |
| 8 | * Calf muscle hypertrophy (HP:0008981) | 5.90127927 |
| 9 | Myoglobinuria (HP:0002913) | 5.76274421 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.60542343 |
| 11 | Ventricular tachycardia (HP:0004756) | 5.59300767 |
| 12 | Nemaline bodies (HP:0003798) | 5.33639567 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 5.02425784 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.90783372 |
| 15 | Subaortic stenosis (HP:0001682) | 4.83446715 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.83446715 |
| 17 | * Abnormality of the calf musculature (HP:0001430) | 4.80759965 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.56552412 |
| 19 | Atrial fibrillation (HP:0005110) | 4.48327350 |
| 20 | Myotonia (HP:0002486) | 4.24704610 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 4.18962422 |
| 22 | * Lipoatrophy (HP:0100578) | 4.06805438 |
| 23 | Supraventricular tachycardia (HP:0004755) | 4.04795993 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 4.03235649 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 3.95902640 |
| 26 | Distal arthrogryposis (HP:0005684) | 3.93373780 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.93013033 |
| 28 | Muscle stiffness (HP:0003552) | 3.85990278 |
| 29 | Bundle branch block (HP:0011710) | 3.76055512 |
| 30 | Myopathic facies (HP:0002058) | 3.75837211 |
| 31 | * Difficulty running (HP:0009046) | 3.68183644 |
| 32 | Palpitations (HP:0001962) | 3.59910127 |
| 33 | * Dilated cardiomyopathy (HP:0001644) | 3.52435171 |
| 34 | Round ear (HP:0100830) | 3.51980973 |
| 35 | Syncope (HP:0001279) | 3.36389915 |
| 36 | * Increased connective tissue (HP:0009025) | 3.29197209 |
| 37 | Prolonged QT interval (HP:0001657) | 3.24428878 |
| 38 | Neck muscle weakness (HP:0000467) | 3.21596684 |
| 39 | * Rimmed vacuoles (HP:0003805) | 3.16358779 |
| 40 | Heart block (HP:0012722) | 3.13875654 |
| 41 | Ventricular arrhythmia (HP:0004308) | 3.11741733 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 3.04114442 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 2.97089017 |
| 44 | * Distal lower limb muscle weakness (HP:0009053) | 2.95162274 |
| 45 | Atrioventricular block (HP:0001678) | 2.84694326 |
| 46 | Limb-girdle muscle atrophy (HP:0003797) | 2.68476443 |
| 47 | Ventricular fibrillation (HP:0001663) | 2.65820123 |
| 48 | Ragged-red muscle fibers (HP:0003200) | 2.64377388 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.57368699 |
| 50 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 2.53036122 |
| 51 | Acute necrotizing encephalopathy (HP:0006965) | 2.52147966 |
| 52 | Hepatic necrosis (HP:0002605) | 2.51657471 |
| 53 | * Difficulty climbing stairs (HP:0003551) | 2.48106621 |
| 54 | Calcaneovalgus deformity (HP:0001848) | 2.45941156 |
| 55 | Weak cry (HP:0001612) | 2.45373660 |
| 56 | Frequent falls (HP:0002359) | 2.41280500 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 2.41013726 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.39087503 |
| 59 | Ketoacidosis (HP:0001993) | 2.39071813 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.36508193 |
| 61 | Facial diplegia (HP:0001349) | 2.36199265 |
| 62 | Abnormal EKG (HP:0003115) | 2.34900590 |
| 63 | * Increased variability in muscle fiber diameter (HP:0003557) | 2.31842764 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29709642 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.29702944 |
| 66 | Slender build (HP:0001533) | 2.29155208 |
| 67 | Testicular atrophy (HP:0000029) | 2.27502560 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.24013867 |
| 69 | * Areflexia of lower limbs (HP:0002522) | 2.22891810 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.22049309 |
| 71 | Gowers sign (HP:0003391) | 2.21743361 |
| 72 | Deformed tarsal bones (HP:0008119) | 2.20619575 |
| 73 | Hepatocellular necrosis (HP:0001404) | 2.20298534 |
| 74 | Acute encephalopathy (HP:0006846) | 2.19316234 |
| 75 | Exercise intolerance (HP:0003546) | 2.16429710 |
| 76 | Hip contracture (HP:0003273) | 2.16254988 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.14434139 |
| 78 | Waddling gait (HP:0002515) | 2.11760539 |
| 79 | Fetal akinesia sequence (HP:0001989) | 2.11600173 |
| 80 | Scapular winging (HP:0003691) | 2.10261281 |
| 81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.10184442 |
| 82 | Progressive muscle weakness (HP:0003323) | 2.09277387 |
| 83 | * Palmoplantar keratoderma (HP:0000982) | 2.08968815 |
| 84 | Progressive macrocephaly (HP:0004481) | 2.08376408 |
| 85 | Limb-girdle muscle weakness (HP:0003325) | 2.07624541 |
| 86 | * Abnormality of the foot musculature (HP:0001436) | 2.06313040 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.06043033 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.02911792 |
| 89 | Abnormality of the calcaneus (HP:0008364) | 2.00368253 |
| 90 | Abnormality of the ischium (HP:0003174) | 1.99910979 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98324871 |
| 92 | Cerebral edema (HP:0002181) | 1.97652429 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96602150 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.96602150 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96223305 |
| 96 | * Muscular dystrophy (HP:0003560) | 1.93865763 |
| 97 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93812480 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.91983424 |
| 99 | Increased CSF lactate (HP:0002490) | 1.91471056 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90461296 |
| 101 | Abnormality of alanine metabolism (HP:0010916) | 1.90461296 |
| 102 | Hyperalaninemia (HP:0003348) | 1.90461296 |
| 103 | Malignant hyperthermia (HP:0002047) | 1.90198791 |
| 104 | Abnormal finger flexion creases (HP:0006143) | 1.89541932 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86172015 |
| 106 | Spinal rigidity (HP:0003306) | 1.84731997 |
| 107 | Hyperkalemia (HP:0002153) | 1.84635608 |
| 108 | Fatigable weakness (HP:0003473) | 1.84338342 |
| 109 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84338342 |
| 110 | Cholelithiasis (HP:0001081) | 1.84049171 |
| 111 | Bulbar palsy (HP:0001283) | 1.82264174 |
| 112 | Ketosis (HP:0001946) | 1.81704648 |
| 113 | * Foot dorsiflexor weakness (HP:0009027) | 1.73688432 |
| 114 | Steppage gait (HP:0003376) | 1.64189867 |
| 115 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.60292426 |
| 116 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.60292426 |
| 117 | Shoulder girdle muscle weakness (HP:0003547) | 1.51845824 |
| 118 | Pelvic girdle muscle weakness (HP:0003749) | 1.51797274 |
| 119 | * Proximal amyotrophy (HP:0007126) | 1.50094672 |
| 120 | Nonprogressive disorder (HP:0003680) | 1.47397845 |
| 121 | Limited hip movement (HP:0008800) | 1.44989788 |
| 122 | Paralysis (HP:0003470) | 1.44104757 |
| 123 | Long clavicles (HP:0000890) | 1.43567178 |
| 124 | Metatarsus adductus (HP:0001840) | 1.39496234 |
| 125 | Oligomenorrhea (HP:0000876) | 1.36859345 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.34902868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.88258216 |
| 2 | PHKG1 | 5.37429644 |
| 3 | PHKG2 | 5.37429644 |
| 4 | PDK4 | 3.48284797 |
| 5 | PDK3 | 3.48284797 |
| 6 | DMPK | 2.93442636 |
| 7 | LMTK2 | 2.91556345 |
| 8 | TRIB3 | 2.74838882 |
| 9 | BCKDK | 2.69438940 |
| 10 | NEK1 | 2.67292300 |
| 11 | PINK1 | 2.59769321 |
| 12 | MYLK | 2.58437208 |
| 13 | PKN2 | 2.38622348 |
| 14 | PIK3CA | 2.33895167 |
| 15 | MUSK | 2.29251671 |
| 16 | PDK2 | 2.19359967 |
| 17 | NME1 | 2.05297827 |
| 18 | MAP2K3 | 1.96532299 |
| 19 | PIK3CG | 1.83707040 |
| 20 | MAP3K7 | 1.66737169 |
| 21 | TIE1 | 1.66323262 |
| 22 | STK24 | 1.47551661 |
| 23 | MAPK12 | 1.43849271 |
| 24 | MARK1 | 1.29919916 |
| 25 | LIMK1 | 1.14585711 |
| 26 | MAPKAPK3 | 1.10574133 |
| 27 | GRK7 | 1.07926564 |
| 28 | PAK3 | 1.02662702 |
| 29 | CAMK2D | 1.00287521 |
| 30 | PRKAA1 | 0.97855748 |
| 31 | PRKAA2 | 0.97332730 |
| 32 | ILK | 0.94184750 |
| 33 | MAP3K3 | 0.92742282 |
| 34 | RIPK1 | 0.88283264 |
| 35 | TRPM7 | 0.86748477 |
| 36 | MOS | 0.84072189 |
| 37 | MAP2K4 | 0.80349309 |
| 38 | ROCK1 | 0.80221661 |
| 39 | ZAK | 0.78199547 |
| 40 | MAP3K5 | 0.77940844 |
| 41 | PKN1 | 0.76619412 |
| 42 | CCNB1 | 0.75776783 |
| 43 | MAP2K6 | 0.73939230 |
| 44 | DYRK1B | 0.73708449 |
| 45 | * PRKD1 | 0.72544701 |
| 46 | EPHB1 | 0.69517457 |
| 47 | NEK9 | 0.67520093 |
| 48 | INSRR | 0.65455526 |
| 49 | ERBB3 | 0.62444007 |
| 50 | MAP3K6 | 0.58936575 |
| 51 | FLT3 | 0.58480084 |
| 52 | MAP2K1 | 0.58224930 |
| 53 | STK4 | 0.58171900 |
| 54 | CAMK2B | 0.57074534 |
| 55 | CDC42BPA | 0.56910752 |
| 56 | CAMK4 | 0.56581888 |
| 57 | TGFBR2 | 0.56130661 |
| 58 | PDGFRA | 0.54914557 |
| 59 | STK38L | 0.53268593 |
| 60 | CAMK2G | 0.52347638 |
| 61 | MAP3K13 | 0.52011674 |
| 62 | WNK4 | 0.51838769 |
| 63 | KSR2 | 0.50876084 |
| 64 | PRKACB | 0.50345241 |
| 65 | AKT2 | 0.49328712 |
| 66 | ROCK2 | 0.47274895 |
| 67 | TAOK1 | 0.45434150 |
| 68 | STK38 | 0.44493147 |
| 69 | DAPK3 | 0.42419054 |
| 70 | RPS6KL1 | 0.41057523 |
| 71 | RPS6KC1 | 0.41057523 |
| 72 | PRKACA | 0.39290590 |
| 73 | MAPK11 | 0.39074804 |
| 74 | PTK6 | 0.38795395 |
| 75 | PDPK1 | 0.38579660 |
| 76 | MAP3K11 | 0.37483899 |
| 77 | WNK1 | 0.37480604 |
| 78 | EPHA3 | 0.37467162 |
| 79 | PRPF4B | 0.36370043 |
| 80 | SIK1 | 0.36249717 |
| 81 | ICK | 0.36016094 |
| 82 | TBK1 | 0.35118250 |
| 83 | KDR | 0.34148793 |
| 84 | SGK2 | 0.34122189 |
| 85 | RPS6KA6 | 0.34118740 |
| 86 | CAMK1 | 0.34081231 |
| 87 | PRKACG | 0.33345916 |
| 88 | PTK2B | 0.33203107 |
| 89 | PDK1 | 0.30609112 |
| 90 | TAOK2 | 0.29585372 |
| 91 | * CAMK2A | 0.29443772 |
| 92 | SGK1 | 0.28677106 |
| 93 | MAPK10 | 0.28091420 |
| 94 | NME2 | 0.27741974 |
| 95 | MAP3K1 | 0.26547678 |
| 96 | RPS6KA1 | 0.25886278 |
| 97 | ZAP70 | 0.25776189 |
| 98 | MARK2 | 0.25232988 |
| 99 | PRKCH | 0.24883870 |
| 100 | PRKG1 | 0.24784456 |
| 101 | FER | 0.21657730 |
| 102 | SGK3 | 0.21515442 |
| 103 | PRKCE | 0.21399770 |
| 104 | MAPK7 | 0.19327618 |
| 105 | LATS2 | 0.19184925 |
| 106 | LATS1 | 0.19078848 |
| 107 | RPS6KB1 | 0.18475249 |
| 108 | RPS6KB2 | 0.18291662 |
| 109 | * RPS6KA3 | 0.17108536 |
| 110 | MARK3 | 0.16616350 |
| 111 | MTOR | 0.16206832 |
| 112 | PAK6 | 0.16136525 |
| 113 | SGK223 | 0.16044417 |
| 114 | SGK494 | 0.16044417 |
| 115 | ARAF | 0.15692421 |
| 116 | LRRK2 | 0.15536369 |
| 117 | RET | 0.15208185 |
| 118 | JAK1 | 0.14011441 |
| 119 | STK11 | 0.13977834 |
| 120 | NLK | 0.13782467 |
| 121 | EPHB2 | 0.13655732 |
| 122 | EEF2K | 0.13638447 |
| 123 | FGFR4 | 0.13183009 |
| 124 | RPS6KA2 | 0.12848932 |
| 125 | MAPK4 | 0.12550764 |
| 126 | PRKD3 | 0.12032614 |
| 127 | DAPK2 | 0.11559200 |
| 128 | MAPK9 | 0.08854609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.75121815 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.29066835 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.14845953 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.73279678 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.62845901 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32077669 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22757917 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.98946520 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.87727015 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.69782954 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69370095 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.49947191 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31169643 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23921778 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.12443944 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02928771 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78874361 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75360229 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69090548 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66913969 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49748239 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.47009619 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42325652 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.31326707 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.30001761 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25598253 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22924946 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20920874 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18235908 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12954317 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03071384 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00931425 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99908303 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97558887 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96255131 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91936172 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85393713 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84295429 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83514887 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82462997 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75798649 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73900909 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 0.71097256 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70204968 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70026743 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69226728 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67839646 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66454832 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 0.64257720 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62438625 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 0.57683766 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57646536 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57504195 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57468848 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56760650 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56695787 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54466167 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52533701 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50073710 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.48755196 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47471038 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.47204647 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46203118 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40741189 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36277869 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.34064073 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32700157 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32260243 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31048629 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29167921 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28743187 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28502941 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27828704 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.27405942 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.25889794 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25611911 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24195790 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23237390 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23218612 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22992027 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.22199688 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21849787 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21808204 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21530983 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20860142 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20857930 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20647375 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19241984 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19141327 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18569817 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.18256344 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17776544 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16976830 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15641204 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15134560 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.14455995 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.13724313 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13344459 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10519497 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09780760 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.09093698 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08734832 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07660600 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06471756 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.05763987 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.05600213 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.05392174 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.03417301 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.03344202 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02673558 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.00668187 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0240438 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0080412 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.0069124 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0046982 |

